
Facts about COVID-19
- The 2019 novel coronavirus disease (COVID-19) is a new virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- COVID-19 is thought to spread from person to person in close contact through respiratory droplets
- These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. It is also possible that a person can catch COVID-19 by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes
- Currently, previous testing for COVID-19 has included only a nasopharyngeal (NP) swab, which is tested for the presence of DNA from the virus
Facts about the Vibrant COVID-19 Panel
- Vibrant has developed a novel test for COVID-19. Vibrant’s COVID-19 panel is a highly sensitive and accurate finger-prick serum assay for viral antibodies, as materials such as NP swabs and fecal testing swabs are limited to emergency and critical institutions only at this time
- Our test was internally developed and validated according to FDA EUA requirements. The independent review of this validation by the FDA is pending. This test does not require confirmation by CDC prior to reporting results
- Vibrant’s COVID-19 ImmuneCheck looks specifically for IgM, IgA, and IgG antibodies against the spike proteins and 4 viral antigens of Covid-19 that will help assess your immunity against this novel virus
Why Test Antibodies to COVID-19?
Antibodies have been found to be highly sensitive biomarkers in infectious disease diagnosis. Previous studies on SARS, MERS, and more recently the ones on SARS-CoV2 have shown IgM antibodies to appear about 3 days from infection and IgG antibodies appear after 8 days. Profiling an individual’s antibody response is the only way to determine infections with few or no symptoms.
Please note:
- A patient cannot order their own tests
- A doctor’s requisition is required for all testing
Only healthcare providers licensed in their state may order laboratory testing.
IgM, IgG, and IgA Antibodies to:
- SARS-CoV-2 Nucleoprotein
- SARS-CoV-2 Spike Glycoprotein (S1)
- SARS-CoV-2 Spike Glycoprotein (S2)
- SARS-CoV-2 Receptor Binding Domain
Quick Interpretation of Results
Advantage of testing all three types of antibodies:
- The importance of combination IgM, IgG, and IgA detection in conjunction with other tests such as nucleic acid testing in nasal or fecal swabs should provide the best detection sensitivity and allow for better interpretation as below:
- IgM
- IgG/IgA
- NEG
- NEG
- Patient may not be infected or in the window of infection if DNA results are positive from NP or fecal swabs. Consider follow up within few days if symptoms persist or refer patient out for a confirmatory NP swab test.
- POS
- NEG
- Patient may be in the early stage of infection
- POS
- POS
- Patient is in the active phase of infection
- NEG
- POS
- Patient may be in the late or recurrent stage of infection
The CDC reports that the following symptoms may appear 2-28 days after exposure:
- Coughing
- Fever
- Shortness of breath
- Shortness of breath
- Gastrointestinal distress
-
- Diarrhea
- Abdominal cramping
- Fatigue
- Body aches
- Headaches
In order to place an order for the Vibrant COVID-19 test panel, you must have a provider account with Vibrant America. If you already have an account, please log in to your provider portal here to place orders:
If you do not have a provider account but wish to open one, free of charge, please fill out the form below to create an account so that you may begin ordering:
Recommended Tests to Consider